Local injection of CCL19-expressing mesenchymal stem cells augments the therapeutic efficacy of anti-PD-L1 antibody by promoting infiltration of immune cells

number of downloads : ?

Use this link to cite this item : https://ir.lib.shimane-u.ac.jp/52831

language	eng
Author	Iida, Yuichi YOSHIKAWA, Rintaro Murata, Akihiko Molecular and Cellular Biology, Tottori University Faculty of Medicine, Yonago, Tottori, Japan. Kotani, Hitoshi Kazuki, Yasuhiro Biomedical Science, Tottori University Faculty of Medicine, Yonago, Tottori, Japan. Oshimura, Mitsuo Chromosome Engineering Research Center, Tottori University, Yonago, Tottori, Japan. MATSUZAKI, Yumi Harada, Mamoru
Subject	cell engineering; dendritic cells; immunotherapy; programmed cell death 1 receptor; tumor microenvironment
Journal Title	JOURNAL FOR IMMUNOTHERAPY OF CANCER
Volume	8
Issue	2
ISSN（Online）	2051-1426
Published Date	2020
DOI	10.1136/jitc-2020-000582
PubMed ID	32675195
Publisher	BMJ PUBLISHING GROUP
NII Type	Journal Article
OAI-PMH Set	Faculty of Medicine
Remark	This study was supported in part by JSPS KAKENHI Grant (no. JP19K16713 to Y.Iida), Shimane University WAKATE supporting project and SUIGAN project.